Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Velayudhan, Shaji R  [Clear All Filters]
Journal Article
Dahariya S, Raghuwanshi S, Thamodaran V, Velayudhan SR, Gutti RKumar. . J Pharmacol Exp Ther. 2022.
Joshi G, Arthur NBeryl Jane, Geetha TS, Datari PVenkateswa, Modak K, Roy D, Chaudhury ADutta, Sundaraganesan P, Priyanka S, Na F, et al. Comprehensive laboratory diagnosis of Fanconi anaemia: comparison of cellular and molecular analysis. J Med Genet. 2023.
Rani S, Thamodaran V, Nandy K, Fouzia NA, Maddali M, Rajesh P, Vijayanand S, David E, Velayudhan SR. Establishment and characterization of CSCRi006-A: an induced pluripotent stem cell line generated from a patient with Diamond-Blackfan Anemia (DBA) carrying ribosomal protein S19 (RPS19) mutation. Hum Cell. 2023.
Ravi NSam, Wienert B, Wyman SK, Bell HWilliam, George A, Mahalingam G, Vu JT, Prasad K, Bandlamudi BPrasad, Devaraju N, et al. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin. Elife. 2022;11.
Jebanesan DZechariah, Illangeswaran RStephen St, Rajamani BM, Vidhyadharan RThalayattu, Das S, Bijukumar NK, Balakrishnan B, Mathews V, Velayudhan SR, Balasubramanian P. Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia. Ann Hematol. 2024.
Manian KV, Aalam SMohammed M, Bharathan SP, Srivastava A, Velayudhan SR. Understanding the Molecular Basis of Heterogeneity in Induced Pluripotent Stem Cells. Cell Reprogram. 2015.